Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (417)

« Back to Publications

The heterogeneity of symptom reporting across study sites: a secondary analysis of a randomised placebo-controlled multicentre antimalarial trial.

Thriemer K. et al, (2023), BMC Med Res Methodol, 23

Severe falciparum malaria in pregnancy in Southeast Asia: a multi-centre retrospective cohort study.

Saito M. et al, (2023), BMC Med, 21

Spatiotemporal Evolution of SARS-CoV-2 Alpha and Delta Variants during Large Nationwide Outbreak of COVID-19, Vietnam, 2021.

Tam NT. et al, (2023), Emerg Infect Dis, 29, 1002 - 1006

Lineage-informative microhaplotypes for spatio-temporal surveillance of Plasmodium vivax malaria parasites.

Siegel SV. et al, (2023), medRxiv

Pf7: an open dataset of Plasmodium falciparum genome variation in 20,000 worldwide samples.

MalariaGEN . et al, (2023), Wellcome Open Res, 8

A molecular barcode and web-based data analysis tool to identify imported Plasmodium vivax malaria.

Trimarsanto H. et al, (2022), Commun Biol, 5

Comparison of Antibody Responses and Parasite Clearance in Artemisinin Therapeutic Efficacy Studies in the Democratic Republic of Congo and Asia.

Cutts JC. et al, (2022), J Infect Dis, 226, 324 - 331

Quantitative bacterial counts in the bone marrow of Vietnamese patients with typhoid fever.

Van Be Bay P. et al, (2022), Trans R Soc Trop Med Hyg, 116, 736 - 744

Triple therapy with artemether-lumefantrine plus amodiaquine versus artemether-lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial.

Peto TJ. et al, (2022), Lancet Infect Dis, 22, 867 - 878

Artemisinin resistance in the malaria parasite, Plasmodium falciparum, originates from its initial transcriptional response.

Zhu L. et al, (2022), Commun Biol, 5

Temporal distribution of Plasmodium falciparum recrudescence following artemisinin-based combination therapy: an individual participant data meta-analysis.

WorldWide Antimalarial Resistance Network Methodology Study Group ., (2022), Malar J, 21

Tafenoquine exposure assessment, safety, and relapse prevention efficacy in children with Plasmodium vivax malaria: open-label, single-arm, non-comparative, multicentre, pharmacokinetic bridging, phase 2 trial.

Vélez ID. et al, (2022), Lancet Child Adolesc Health, 6, 86 - 95

Anti-Gametocyte Antigen Humoral Immunity and Gametocytemia During Treatment of Uncomplicated Falciparum Malaria: A Multi-National Study.

O'Flaherty K. et al, (2022), Front Cell Infect Microbiol, 12

An open dataset of Plasmodium vivax genome variation in 1,895 worldwide samples.

MalariaGEN . et al, (2022), Wellcome Open Res, 7

An open dataset of Plasmodium vivax genome variation in 1,895 worldwide samples

Adam I. et al, (2022), Wellcome Open Research, 7

Load More

1
2
3
4
5
6
7
...
»